TO · PRM.TO · ASSET MANAGEMENT

Big Pharma Split Corp.

$16.02as of 2026-11-13 · Mkt cap 16.84M

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Unlock with Pro

Financial Services · Asset Management Oakville, ON L6j 4A5 harvestportfolios.com

How the business is doing

Fiscal 2017–2025, USD

Revenue
$1.45M-14% 5y CAGRd
20172025
Net income
$4.4M+74.8% 5y CAGRd
20172025
Free cash flow
-$-1.06M
20172025
Total equity
$18.3M+6.7% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Big Pharma Split Corp.

        Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

        CEO
        Louis Michael Kovacs
        Employees
        0
        Beta
        0.69

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.